Literature DB >> 2894902

A comparative evaluation of intubating doses of atracurium, d-tubocurarine, pancuronium and vecuronium in children.

C J Montgomery1, D J Steward.   

Abstract

To determine the onset and recovery times and haemodynamic effects of intubating doses of atracurium (0.4 mg.kg-1), d-tubocurarine (0.8 mg.kg-1), pancuronium (0.12 mg.kg-1), and vecuronium (0.07 mg.kg-1), sixty-seven children aged one to eight years were studied under halothane and nitrous oxide anaesthesia. The time to maximum twitch depression and the time to recovery to T1/Tc 25 per cent were recorded with an integrated evoked EMG recorder. The heart rate and systolic blood pressure were recorded for five minutes after drug administration and prior to intubation. There was no difference in onset times between drugs. The recovery time to T1/Tc 25 per cent following vecuronium (25.5 +/- 6.3 min) was shorter than following atracurium (37.5 +/- 7.0 min). Recovery times for d-tubocurarine and pancuronium were greater than sixty minutes. Elevation of heart rate occurred after administration of pancuronium (+29.8 per cent to +38.6 per cent) and d-tubocurarine (+31 per cent to +34.9 per cent), but no change was observed after atracurium or vecuronium. Elevation of blood pressure was greatest following pancuronium (+10.8 to +14.8 per cent). No significant change was observed following atracurium or vecuronium. A transient lowering of blood pressure (-9.3 per cent) occurred following d-tubocurarine.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2894902     DOI: 10.1007/BF03010542

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  13 in total

1.  A clinical comparison between tubocurarine and pancuronium in children.

Authors:  D A Nightingale; G H Bush
Journal:  Br J Anaesth       Date:  1973-01       Impact factor: 9.166

2.  Safety and efficacy of atracurium in adolescents and children anesthetized with halothane.

Authors:  N G Goudsouzian; L M Liu; C J Coté; M Gionfriddo; G D Rudd
Journal:  Anesthesiology       Date:  1983-11       Impact factor: 7.892

Review 3.  Clinical pharmacology of vecuronium and atracurium.

Authors:  R D Miller; S M Rupp; D M Fisher; R Cronnelly; M R Fahey; Y J Sohn
Journal:  Anesthesiology       Date:  1984-10       Impact factor: 7.892

4.  Clinical pharmacology of atracurium in paediatric patients.

Authors:  B W Brandom; G D Rudd; D R Cook
Journal:  Br J Anaesth       Date:  1983       Impact factor: 9.166

5.  Comparison of the effects of atracurium and tubocurarine on heart rate and arterial pressure in anaesthetized man.

Authors:  P K Barnes; V J Thomas; I Boyd; T Hollway
Journal:  Br J Anaesth       Date:  1983       Impact factor: 9.166

6.  Neuromuscular effects of vecuronium (ORG NC45) in infants and children during N2O, halothane anesthesia.

Authors:  D M Fisher; R D Miller
Journal:  Anesthesiology       Date:  1983-06       Impact factor: 7.892

7.  Safety and efficacy of vecuronium in adolescents and children.

Authors:  N G Goudsouzian; J J Martyn; L M Liu; M Gionfriddo
Journal:  Anesth Analg       Date:  1983-12       Impact factor: 5.108

8.  Spontaneous recovery of neuromuscular function after atracurium in pediatric patients.

Authors:  O A Meretoja; I Kalli
Journal:  Anesth Analg       Date:  1986-10       Impact factor: 5.108

9.  Clinical pharmacology of vecuronium in children. Studies during nitrous oxide and halothane in oxygen anaesthesia.

Authors:  C Meistelman; J P Loose; C Saint-Maurice; M M Delleur; G L da Silva
Journal:  Br J Anaesth       Date:  1986-09       Impact factor: 9.166

10.  Histamine release during the administration of atracurium or vecuronium in children.

Authors:  N G Goudsouzian; E T Young; J Moss; L M Liu
Journal:  Br J Anaesth       Date:  1986-11       Impact factor: 9.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.